Cellular and humoral immune responses after short-term oral hormone therapy in postmenopausal women

References

• Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996;17:369–84
   PubMed Web of Science ®Google Scholar
• Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999;103: 282–8
   PubMed Web of Science ®Google Scholar
• Benten WPM, Becker A, Schmitt-Wrede HP, Wunderlich F. Developmental regulation of intracellular and surface androgen receptors in T cells. Steroids 2002;67:925–31
   PubMed Web of Science ®Google Scholar
• Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11: 411–23
   PubMed Web of Science ®Google Scholar
• Gameiro CM, Romão F, Castelo-Branco C. Menopause and aging: changes in the immune system – a review. Maturitas 2010;67:316–20
   PubMed Web of Science ®Google Scholar
• Albrecht AE, Hartmann BW, Scholten C, Huber JC, Kalinowska W, Zielinski CC. Effect of estrogen replacement therapy on natural killer cell activity in postmenopausal women. Maturitas 1996;25:217–22
   PubMed Web of Science ®Google Scholar
• Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010;120:105–15
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J, Koditz R, Pfohl M, Schantz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90–119
   PubMed Web of Science ®Google Scholar
• Menselsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–11
   PubMed Web of Science ®Google Scholar
• Sanches-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995; 122:430–3
   PubMed Web of Science ®Google Scholar
• Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004;172:1–6
   PubMed Web of Science ®Google Scholar
• Angeli F, Angeli E, Ambrosio G, . Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular risk. Obstet Gynecol 2010;115:695–703
   PubMed Web of Science ®Google Scholar
• Smith R, Studd JWW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 1992;85:612–13
   PubMed Web of Science ®Google Scholar
• D'Elia HF, Carlsten H. The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. Scand J Immunol 2008;68:661–7
   PubMed Web of Science ®Google Scholar
• Kane SV, Reddy D. Hormone replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2008;103:1193–6
   PubMed Web of Science ®Google Scholar
• Ho PC, Tang GW, Lawton JW. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after estrogen replacement. Hum Reprod 1993;8: 714–16
   PubMed Web of Science ®Google Scholar
• Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol 2004;63:31–8
   PubMed Web of Science ®Google Scholar
• Straub RH, Hense HW, Andus T, Scholmerich J, Riegger GA, Schunkert H. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab 2000;85:1340–4
   PubMed Web of Science ®Google Scholar
• Manyonda IT, Pereira RS, Makinde V, Brincat M, Varma RT. Effect of 17β-oestradiol on lymphocyte subpopulations, delayed cutaneous hypersensitivity responses and mixed lymphocyte reactions in post-menopausal women. Maturitas 1992;14: 201–10
   PubMed Web of Science ®Google Scholar
• Porter VR, Greendale GA, Schocken M, Zhu X, Effros RB. Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol 2001;36:311–26
   PubMed Web of Science ®Google Scholar
• Eichler F, Keiling R. Variations in percentages of lymphocyte subtypes during the menstrual cycle in women. Biomed Pharmacother 1988;42:285–7
   PubMed Web of Science ®Google Scholar
• Stopinska-Gluszak U, Waligóra J, Grzela T, . Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol 2006;69:65–75
   PubMed Web of Science ®Google Scholar
• Bland M. An Introduction to Medical Statistics, 3rd. Oxford: Oxford University Press, 2000:137–55
   Google Scholar
• Yang JH, Chen CD, Wu MY, Chao KH, Yang YS, Ho HN. Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women. Fertil Steril 2000;74:261–7
   PubMed Web of Science ®Google Scholar
• Kamada M, Irahara M, Maegawa M, Yasui T, Takeji T, Yamada M. Effect of hormone replacement therapy on post-menopausal changes of lymphocytes and T cell subsets. J Endocrinol Invest 2000;23:376–82
   PubMed Web of Science ®Google Scholar
• Ben-Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 1995;34:363–9
   PubMed Web of Science ®Google Scholar
• Margolis KL, Manson JE, Greenland P, . Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative observational study. Arch Intern Med 2005;165:500–8
   PubMed Web of Science ®Google Scholar
• Berliner S, Rogowski O, Rotstein R, . Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis. Cardiology 2000;94:19–25
   PubMed Web of Science ®Google Scholar
• Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A. Total lymphocyte count and femoral bone mineral density in postmenopausal women. J Bone Miner Metab 2004;22:58–63
   PubMed Web of Science ®Google Scholar
• Fahlman MM, Boardley D, Flynn MG, Bouillon LE, Lambert CP, Braun WA. Effects of hormone replacement therapy on selected indices of immune function in postmenopausal women. Gynecol Obstet Invest 2000;50:189–93
   PubMed Web of Science ®Google Scholar
• Ho PC, Tang GW, Lawton JW. Lymphocyte subsets with estrogen deficiency. J Reprod Immunol 1991;20:85–91
   PubMed Web of Science ®Google Scholar
• Blum M, Zacharovich D, Pery J, Kitai E. Lowering effect of estrogen replacement treatment on immunoglobulins in menopausal women. Rev Fr Gynecol Obstet 1990;85:207–9
   PubMedGoogle Scholar
• Yalmazer M, Fenkci V, Fenkci S, Aktepe O, Sonmezer M, Kurtay G. Association of serum complement (C3, C4) and immunoglobin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women. Hum Reprod 2003;18: 1531–5
   PubMed Web of Science ®Google Scholar
• Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11:1043–51
   PubMed Web of Science ®Google Scholar
• Yasui T, Maegawa M, Tmita J, . Change in serum cytokine concentrations during the menopausal transition. Maturitas 2007;56:396–403
   PubMed Web of Science ®Google Scholar
• Cioffi M, Esposito K, Vietri MT, . Cytokine pattern in postmenopause. Maturitas 2002;41:187–92
   PubMed Web of Science ®Google Scholar
• Brooks-Asplund EM, Tupper CE, Daun JM, Kenney WL, Cannon JG. Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women. Cytokine 2002;19:193–200
   PubMed Web of Science ®Google Scholar
• Wilson R, Spier A, Ewan J, Johnson P, Jenkins C, Carr S. Effects of high dose oestrogen therapy on circulation inflammatory markers. Maturitas 2009;62:281–6
   PubMed Web of Science ®Google Scholar
• Edwards KM, Mills PJ. Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6. Maturitas 2008;61: 330–3
   PubMed Web of Science ®Google Scholar
• Lakoski SG, Herrington DM. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article. Climacteric 2005;8:317–26
   PubMed Web of Science ®Google Scholar
• Mallat Z, Besnard S, Duriez M, . Protective role of interleukin 10 in atherosclerosis. Circ Res 1999, 85:e17–24
   PubMed Web of Science ®Google Scholar
• Ersler WB, Seen WH, Dinkley N. The role of interleukin-6 in certain age-related diseases. Drugs Ageing 1994;5:358–65
   PubMed Web of Science ®Google Scholar
• Saucedo R, Rico G, Basurto L, Ochoa R, Zárate A. Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response. Gynecol Obstet Invest 2002;53:114–17
   PubMed Web of Science ®Google Scholar
• Kamada M, Irahara M, Maegawa M, . Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 2001;184:309–14
   PubMed Web of Science ®Google Scholar
• Berg G, Ekerfelt C, Hammar M, Lindgren R, Matthiesen L, Ernerudh J. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study. Am J Reprod Immunol 2002;48:63–9
   PubMed Web of Science ®Google Scholar
• Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 2006;54:298–302
   PubMed Web of Science ®Google Scholar